Eligard Description

leuprorelin

Manufacturer:

Distributor:

DCH Auriga - Healthcare

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

One prefilled syringe with powder for solution for injection contains 22.5 mg or 45 mg leuprorelin acetate, respectively equivalent to 20.87 mg or 41.7 mg leuprorelin.
Excipients/Inactive Ingredients: Solvent (Syringe A): N-Methylpyrrolidone.
22.5 mg: Poly(DL-lactic-co-glycolic-acid) (75:25).
45 mg: Poly(DL-lactic-co-glycolic-acid) (85:15).
Powder (Syringe B): None.

Exclusive offer for doctors

Already a member? Sign in